Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00779246 · ClinicalTrials.gov registry record · NA
Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections
A NA study, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- NA
- Development phase
- 1,518
- Enrollment target
NCT00779246: Completed NA study, sponsored by Christiana Care Health Services.
NCT00779246 is a NA study that has completed, run by Christiana Care Health Services. The registered enrollment target is 1,518 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00779246, a NA study, has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,518 participants
- Enrollment target
Study Summary
This pilot study in our medical intensive care unit will evaluate the clinical and cost-effectiveness of an active surveillance program for methicillin-resistant Staphylococcus aureus (MRSA), compared to routine daily bathing with chlorhexidine gluconate (CHG)-impregnated cloths. Outcomes include rate of MRSA acquisition, and of other hospital-acquired infections (e.g., catheter-associated bloodstream infections).
Primary Outcome
Number of patients who acquired MRSA by the time of ICU discharge (based on nasal swab or clinical culture).
Interventions
- DRUG Chlorhexidine gluconate
- OTHER Nasal swabs for MRSA culture
- OTHER Contact isolation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,518 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-07 |
| Phase | NA |
What the finished NCT00779246 record still lists
NCT00779246 is an interventional study that assigns participants to a tested intervention. Its 1,518 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Chlorhexidine gluconate is the first listed.
NCT00779246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00779246 about?
NCT00779246 is a clinical study titled "Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections". This pilot study in our medical intensive care unit will evaluate the clinical and cost-effectiveness of an active surveillance program for methicillin-resistant Staphylococcus aureus (MRSA), compared to routine daily bathing with chlorhexidine gluconate (CHG)-impregnated cloths. Outcomes include ra...
What is the current status of trial NCT00779246?
This trial is currently completed. It is a NA study. The enrollment target is 1,518 participants. The study started on 2008-06. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00779246?
The interventions under investigation include: Chlorhexidine gluconate (DRUG), Nasal swabs for MRSA culture (OTHER), Contact isolation (OTHER).
Who is sponsoring clinical trial NCT00779246?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00779246's enrollment target sits among peer trials
1,518 65th of 2000 higher than 1,936 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07232017 · 1,520 participants
Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic
- NCT05633654 · 1,514 participants · Phase 3
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- NCT07136623 · 1,513 participants
Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope
- NCT06876714 · 1,524 participants · Phase 3
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia